AUTHOR=Liu Wen-Pan , Li Peng , Zhan Xu , Qu Lai-Hao , Xiong Tao , Hou Fang-Xia , Wang Jun-Kui , Wei Na , Liu Fu-Qiang 

TITLE=Identification of molecular subtypes of coronary artery disease based on ferroptosis- and necroptosis-related genes

JOURNAL=Frontiers in Genetics

VOLUME=13

YEAR=2022

URL=https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2022.870222

DOI=10.3389/fgene.2022.870222

ISSN=1664-8021

ABSTRACT=<p><bold>Aim:</bold> Coronary artery disease (CAD) is a heterogeneous disorder with high morbidity, mortality, and healthcare costs, representing a major burden on public health. Here, we aimed to improve our understanding of the genetic drivers of ferroptosis and necroptosis and the clustering of gene expression in CAD in order to develop novel personalized therapies to slow disease progression.</p><p><bold>Methods:</bold> CAD datasets were obtained from the Gene Expression Omnibus. The identification of ferroptosis- and necroptosis-related differentially expressed genes (DEGs) and the consensus clustering method including the classification algorithm used km and distance used spearman were performed to differentiate individuals with CAD into two clusters (cluster A and cluster B) based expression matrix of DEGs. Next, we identified four subgroup-specific genes of significant difference between cluster A and B and again divided individuals with CAD into gene cluster A and gene cluster B with same methods. Additionally, we compared differences in clinical information between the subtypes separately. Finally, principal component analysis algorithms were constructed to calculate the cluster-specific gene score for each sample for quantification of the two clusters.</p><p><bold>Results:</bold> In total, 25 ferroptosis- and necroptosis-related DEGs were screened. The genes in cluster A were mostly related to the neutrophil pathway, whereas those in cluster B were mostly related to the B-cell receptor signaling pathway. Moreover, the subgroup-specific gene scores and CAD indices were higher in cluster A and gene cluster A than in cluster B and gene cluster B. We also identified and validated two genes showing upregulation between clusters A and B in a validation dataset.</p><p><bold>Conclusion:</bold> High expression of <italic>CBS</italic> and <italic>TLR4</italic> was related to more severe disease in patients with CAD, whereas <italic>LONP1</italic> and <italic>HSPB1</italic> expression was associated with delayed CAD progression. The identification of genetic subgroups of patients with CAD may improve clinician knowledge of disease pathogenesis and facilitate the development of methods for disease diagnosis, classification, and prognosis.</p>